HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Clinical Interpretation of Genomic Variants from Large Next-Generation Panel (NGS), Whole Exome Sequencing and Whole Transcriptome Sequencing. The project location is USA and the tender is closing on 02 Jun 2020. The tender notice number is 75N91020Q00029, while the TOT Ref Number is 43058410. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Clinical Interpretation of Genomic Variants from Large Next-Generation Panel (NGS), Whole Exome Sequencing and Whole Transcriptome Sequencing

Deadline : 02 Jun 2020

Other Information

Notice Type : Tender

TOT Ref.No.: 43058410

Document Ref. No. : 75N91020Q00029

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Rockville, MD 20850
Primary Point of Contact : Adam Hernandez
adam.hernandez@nih.gov
Phone Number 2402765633

USA
Email :adam.hernandez@nih.gov

Tender Details

Clinical Interpretation of Genomic Variants from Large Next-Generation Panel (NGS), Whole Exome Sequencing and Whole Transcriptome Sequencing

Active Contract Opportunity

Notice ID : 75N91020Q00029

Related Notice

Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier : NATIONAL INSTITUTES OF HEALTH

Office : NIH National Cancer Institute

General Information

Contract Opportunity Type: Special Notice (Original)

All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: May 22, 2020 02:45 pm EDT

Original Response Date: Jun 02, 2020 09:00 am EDT

Inactive Policy: 15 days after response date

Original Inactive Date: Jun 17, 2020

Initiative: None


Classification

Original Set Aside:

Product Service Code: Q301 - MEDICAL- LABORATORY TESTING

NAICS Code: 541990 - All Other Professional, Scientific, and Technical Services

Place of Performance:

Description

The U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Pathology (LP) intends to procure, on a sole source basis, services for the clinical interpretation of genomic variants from large next-generation panel (NGS), whole exome sequencing and whole transcriptome sequencing from Qiagen, LLC, 19300 Germantown Road, Germantown, MD 20874-1415, United States.

The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1(b)(2); and is exempt from the requirements of FAR Part 6. The North American Industry Classification System (NAICS) code is 541990 and the business size standard is $16.5 million.

1.0 BACKGROUND

The Clinical Oncologic Molecular Pathology Sequencing Service (COMPASS) program in the Laboratory of Pathology (LP) located in the Cancer Center for Research (CCR) at the National Cancer Institute (NCI) is committed to advancing genomic research and offering genomic testing so that new treatments, therapies and therapeutics against cancer can be developed. The COMPASS program is developing large NGS panels, whole exome sequencing and whole transcriptome sequencing assays to identify genetic changes in clinical specimens from cancer patients who are being evaluated and/or treated by the intramural program of the National Cancer Institute. These genetic changes include mutations, copy number changes and gene rearrangements. Given the massive amount of genetic data generated from NGS assays and rapidly changing information on clinical trials, professional guidelines, and public databases, it is challenging for the Laboratory of Pathology to accurately surv...

Documents

 Tender Notice